Professor
Weill Cornell Medicine
New York, NY, United States
Dr. Shuibing Chen is the Kilts Family Professor and Vice Chair of Innovation in the Department of Surgery and Director of the Center for Genomic Health at Weill Cornell Medicine. She is an internationally recognized leader in human stem cell biology, disease modeling, and translational discovery. Dr. Chen’s research program focuses on the development and application of human pluripotent stem cell–derived organoids and multi-tissue systems to model human development, disease mechanisms, and therapeutic responses. By integrating chemical biology, functional genomics, single-cell and spatial omics, and emerging AI/ML approaches, her laboratory has established scalable, human-relevant platforms for drug discovery, toxicity testing, and precision medicine. Her work has been published in leading journals, including Nature, Nature Medicine, Nature Cell Biology, Cell Stem Cell, and Cell Metabolism.
In addition to her scientific contributions, Dr. Chen has played a major leadership role in building community-scale research infrastructure. She has served as a Multiple Principal Investigator on several NIH-funded data science and consortium initiatives, including dkNET, PanKbase, and MAI-T1D, with a focus on data standardization, accessibility, and cross-disciplinary collaboration.
Dr. Chen currently serves on the Board of Directors of the International Society for Stem Cell Research and the International Chemical Biology Society. She co-chairs the ISSCR Consortium on Advanced Stem Cell-Based Models in Drug Discovery and Development, fostering global collaboration between academia, industry, and regulatory stakeholders. She also serves on the editorial boards of Cell Stem Cell, Cell Blue and Stem Cell Reports. Her contributions have been recognized with numerous honors, including the New York Stem Cell Foundation Robertson Investigator Award, the American Diabetes Association Innovative Award, the NIH Director’s New Innovator Award, and the ISSCR Dr. Susan Lim Award for Outstanding Young Investigator.
Disclosure information not submitted.
MTS03-01 - Algorithms and Organoids: Transforming Diabetes Therapeutic Discovery
Sunday, June 14, 2026
3:30 PM - 4:15 PM CT